Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kejing Lao, Naichun Ji, Xiaohua Zhang, Wenwei Qiao, Zhishu Tang & Xingchun Gou. (2019) Drug development for Alzheimer’s disease: review. Journal of Drug Targeting 27:2, pages 164-173.
Read now
Read now
Pamela E Potter. (2013) Curcumin: a natural substance with potential efficacy in Alzheimer’s disease. Journal of Experimental Pharmacology 5, pages 23-31.
Read now
Read now
Ken-ichi Hosoya, Masatoshi Tomi & Masanori Tachikawa. (2011) Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood–retinal barrier. Expert Opinion on Drug Delivery 8:12, pages 1571-1587.
Read now
Read now
Daphne Lo & George T Grossberg. (2011) Use of memantine for the treatment of dementia. Expert Review of Neurotherapeutics 11:10, pages 1359-1370.
Read now
Read now
Articles from other publishers (41)
Satoru Esumi, Soichiro Ushio & Yoshito Zamami. (2022) Polypharmacy in Older Adults with Alzheimer’s Disease. Medicina 58:10, pages 1445.
Crossref
Crossref
Caitlyn J. Bartsch & Jacob C. Nordman. (2022) Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression. Frontiers in Behavioral Neuroscience 16.
Crossref
Crossref
María C. Ovejero-Benito, Dolores Ochoa, Teresa Enrique-Benedito, Miriam del Peso-Casado, Pablo Zubiaur, Marcos Navares, Manuel Román & Francisco Abad-Santos. (2022) Pharmacogenetics of Donepezil and Memantine in Healthy Subjects. Journal of Personalized Medicine 12:5, pages 788.
Crossref
Crossref
Diána Martos, Bernadett Tuka, Masaru Tanaka, László Vécsei & Gyula Telegdy. (2022) Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission. Biomedicines 10:4, pages 849.
Crossref
Crossref
Ashutosh Paliwal, Ashwini Kumar Nigam, Jalaj Kumar Gour, Deepak Singh, Pooja Pandey & Manoj Kumar Singh. 2021. Naturally Occurring Chemicals Against Alzheimer's Disease. Naturally Occurring Chemicals Against Alzheimer's Disease
49
63
.
Huarong Zhou, Xiaomei Zhong, Ben chen, Zhangying Wu, Min Zhang, Naikeng Mai, Qi Peng, Xinru Chen, Cong Ouyang, Wanyuan Liang, Chunying Dai, Xingxiao Huang, Weiru Zhang & Yuping Ning. (2020) Interactive effects of elevated homocysteine and late-life depression on cognitive impairment. Journal of Affective Disorders 277, pages 212-217.
Crossref
Crossref
Valery M. Dembitsky, Tatyana A. Gloriozova & Vladimir V. Poroikov. (2020) Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases. Biochemical and Biophysical Research Communications 529:4, pages 1225-1241.
Crossref
Crossref
Sandra Vezmar-Kovačević. (2020) Pharmaceutical care in Alzheimer's disease. Arhiv za farmaciju 70:2, pages 69-80.
Crossref
Crossref
Vimal M. Aga. (2019) When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram. The American Journal of Geriatric Psychiatry 27:10, pages 1099-1107.
Crossref
Crossref
Pallavi Duggal & Sidharth Mehan. (2019) Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings. Journal of Alzheimer's Disease Reports 3:1, pages 179-218.
Crossref
Crossref
Georgia Watt & Tim Karl. (2017) In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease. Frontiers in Pharmacology 8.
Crossref
Crossref
J. Wallach, T. Colestock & A. Adejare. 2017. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
83
107
.
M Brendel, A Jaworska, J Herms, J Trambauer, C Rötzer, F-J Gildehaus, J Carlsen, P Cumming, J Bylund, T Luebbers, P Bartenstein, H Steiner, C Haass, K Baumann & A Rominger. (2015) Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment. Molecular Psychiatry 20:10, pages 1179-1187.
Crossref
Crossref
Mohammad Abbasinazari, Ladan Adib-Eshgh, Azin Rostami, Narges Beyraghi, Shideh Dabir & Reyhaneh Jafari. (2015) Memantine in the prevention or alleviation of electroconvulsive therapy induces cognitive disorders: A placebo controlled trial. Asian Journal of Psychiatry 15, pages 5-9.
Crossref
Crossref
Jonathan J. Evans. 2014. Textbook of Neural Repair and Rehabilitation. Textbook of Neural Repair and Rehabilitation
478
488
.
. 2014. Textbook of Neural Repair and Rehabilitation. Textbook of Neural Repair and Rehabilitation
437
508
.
Jason Pitt. 2014. Biomarkers in Toxicology. Biomarkers in Toxicology
801
815
.
Sandra M. Vetiska & Michael Tymianski. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1381
1402
.
Dantao Peng, Xinrui Yuan & Rui Zhu. (2013) Memantine hydrochloride in the treatment of dementia subtypes. Journal of Clinical Neuroscience 20:11, pages 1482-1485.
Crossref
Crossref
Andrew H. Ford, Leon Flicker, Urvashnee Singh, Varsha Hirani & Osvaldo P. Almeida. (2013) Homocysteine, depression and cognitive function in older adults. Journal of Affective Disorders 151:2, pages 646-651.
Crossref
Crossref
I. Demeter, K. Nagy, T. Farkas, Zs. Kis, K. Kocsis, L. Knapp, L. Gellert, F. Fülöp, L. Vecsei & J. Toldi. (2013) Paradox effects of kynurenines on LTP induction in the Wistar rat. An in vivo study. Neuroscience Letters 553, pages 138-141.
Crossref
Crossref
Paul C. Trippier, Kristin Jansen Labby, Dustin D. Hawker, Jan J. Mataka & Richard B. Silverman. (2013) Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers. Journal of Medicinal Chemistry 56:8, pages 3121-3147.
Crossref
Crossref
Muriel Noetzli, Monia Guidi, Karsten Ebbing, Stephan Eyer, Laurence Wilhelm, Agnès Michon, Valérie Thomazic, Abdel-Messieh Alnawaqil, Sophie Maurer, Serge Zumbach, Panteleimon Giannakopoulos, Armin von Gunten, Chantal Csajka & Chin B. Eap. (2013) Population Pharmacokinetic Study of Memantine: Effects of Clinical and Genetic Factors. Clinical Pharmacokinetics 52:3, pages 211-223.
Crossref
Crossref
Lars Sonde & Kristina Johnell. (2013) Is Drug Treatment for Dementia Followed Up in Primary Care? A Swedish Study of Dementia Clinics and Referring Primary Care Centres. PLoS ONE 8:2, pages e57161.
Crossref
Crossref
Takafumi Noshita, Norihito Murayama, Tetsushi Oka, Ryoko Ogino, Shizuo Nakamura & Teruyoshi Inoue. (2012) Effect of bFGF on neuronal damage induced by sequential treatment of amyloid β and excitatory amino acid in vitro and in vivo. European Journal of Pharmacology 695:1-3, pages 76-82.
Crossref
Crossref
Christopher Exley. (2012) The coordination chemistry of aluminium in neurodegenerative disease. Coordination Chemistry Reviews 256:19-20, pages 2142-2146.
Crossref
Crossref
Antony Bayer. (2012) Progress in diagnosis and management of Alzheimer's disease. Quality in Ageing and Older Adults 13:3, pages 189-196.
Crossref
Crossref
Cédric Annweiler, François R. Herrmann, Bruno Fantino, Bernard Brugg & Olivier Beauchet. (2012) Effectiveness of the Combination of Memantine Plus Vitamin D on Cognition in Patients With Alzheimer Disease. Cognitive and Behavioral Neurology 25:3, pages 121-127.
Crossref
Crossref
R Boada, C Hutaff-Lee, A Schrader, D Weitzenkamp, T A Benke, E J Goldson & A C S Costa. (2012) Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial. Translational Psychiatry 2:7, pages e141-e141.
Crossref
Crossref
MT Klein & M Teitler. (2012) Distribution of 5-ht1E receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study. British Journal of Pharmacology 166:4, pages 1290-1302.
Crossref
Crossref
Rainer Hellweg, Yvonne Wirth, Wolfgang Janetzky & Susanne Hartmann. (2012) Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD. International Journal of Geriatric Psychiatry 27:6, pages 651-656.
Crossref
Crossref
Haythum O. Tayeb, Hyun Duk Yang, Bruce H. Price & Frank I. Tarazi. (2012) Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors. Pharmacology & Therapeutics 134:1, pages 8-25.
Crossref
Crossref
Cédric Annweiler & Olivier Beauchet. (2012) Possibility of a New Anti-Alzheimerʼs Disease Pharmaceutical Composition Combining Memantine and Vitamin D. Drugs & Aging 29:2, pages 81-91.
Crossref
Crossref
Arvid Rongve, Eirik Auning, Uwe Ehrt & Dag Årsland. (2012) Psykose ved Parkinsons sykdom. Tidsskrift for Den norske legeforening 132:2, pages 155-158.
Crossref
Crossref
Wenjun Zhang, Wei Zhang, Zhuyi Li, Jian Hao, Zhuo Zhang, Liu Liu, Ni Mao, Jianting Miao & Lianfeng Zhang. (2012) S14G-Humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice. Pharmacology Biochemistry and Behavior 100:3, pages 361-369.
Crossref
Crossref
Athanasios Koukopoulos, Giulia Serra, Alexia E. Koukopoulos, Daniela Reginaldi & Gino Serra. (2012) The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: Findings from a 12-month naturalistic trial. Journal of Affective Disorders 136:1-2, pages 163-166.
Crossref
Crossref
Gabriel Coll-de-Tuero, Secundino López-Pousa & Joan Vilalta-Franch. (2011) ¿Cuándo suspender el tratamiento farmacológico específico en el Alzheimer?. Atención Primaria 43:11, pages 565-567.
Crossref
Crossref
Nathan Herrmann, Sarah A. Chau, Ida Kircanski & Krista L. Lanctôt. (2011) Current and Emerging Drug Treatment Options for Alzheimerʼs Disease. Drugs 71:15, pages 2031-2065.
Crossref
Crossref
Michelle Braun, David Tupper, Paul Kaufmann, Michael McCrea, Karen Postal, Michael Westerveld, Karen Wills & Teresa Deer. (2011) Neuropsychological Assessment. Cognitive and Behavioral Neurology 24:3, pages 107-114.
Crossref
Crossref
Rüdiger Hardeland. (2011) Cognitive Enhancers in Moderate to Severe Alzheimer's Disease. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6344.
Crossref
Crossref
Ken Nagata, Daiki Takano, Takashi Yamazaki, Tetsuya Maeda, Yuichi Satoh & Taizen Nakase. (2011) 2. Pharmacological Treatment of Dementia.2．薬物療法. Nihon Naika Gakkai Zasshi 100:8, pages 2134-2145.
Crossref
Crossref